Cargando…
Australia (Hepatitis-Associated) Antigen: Physicochemical And Immunological Characteristics
This chapter discusses the discovery, characterization, immunology, and etiological significance of “Australia antigen (Au),” a new antigenic specificity appearing in the serum of patients with serum hepatitis, and carried on characteristic lipoprotein particles. In addition to its original name, gi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press Inc. Published by Elsevier Inc.
1970
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131679/ https://www.ncbi.nlm.nih.gov/pubmed/4993220 http://dx.doi.org/10.1016/S0065-3527(08)60027-5 |
_version_ | 1783517293340262400 |
---|---|
author | Bouvier, George L. Le McCollum, Robert W. |
author_facet | Bouvier, George L. Le McCollum, Robert W. |
author_sort | Bouvier, George L. Le |
collection | PubMed |
description | This chapter discusses the discovery, characterization, immunology, and etiological significance of “Australia antigen (Au),” a new antigenic specificity appearing in the serum of patients with serum hepatitis, and carried on characteristic lipoprotein particles. In addition to its original name, given before its relationship to viral hepatitis became known, the antigen has also been given the designations, including Au(1) , SH antigen, Au/SH antigen, hepatitis antigen, and hepatitis-associated antigen (HAA). The synthesis of Au antigen, and its appearance in the serum, is specifically associated with infection by the causal agent of the SH type of viral hepatitis. The chapter discusses properties of the antigen, and of the particles which carry the Au specificity. It also discusses various serological techniques for Au antigen, such as two-dimensional double immunodiffusion (ID), complement fixation (CF), immunofluorescence (IF), reversed passive hemagglutination (RPHA) of antibody-coated red cells, immune electron microscopy (IEM), immunoelectroosmophoresis (IEOP), and radioimmunoassay (RIA). |
format | Online Article Text |
id | pubmed-7131679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1970 |
publisher | Academic Press Inc. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71316792020-04-08 Australia (Hepatitis-Associated) Antigen: Physicochemical And Immunological Characteristics Bouvier, George L. Le McCollum, Robert W. Adv Virus Res Article This chapter discusses the discovery, characterization, immunology, and etiological significance of “Australia antigen (Au),” a new antigenic specificity appearing in the serum of patients with serum hepatitis, and carried on characteristic lipoprotein particles. In addition to its original name, given before its relationship to viral hepatitis became known, the antigen has also been given the designations, including Au(1) , SH antigen, Au/SH antigen, hepatitis antigen, and hepatitis-associated antigen (HAA). The synthesis of Au antigen, and its appearance in the serum, is specifically associated with infection by the causal agent of the SH type of viral hepatitis. The chapter discusses properties of the antigen, and of the particles which carry the Au specificity. It also discusses various serological techniques for Au antigen, such as two-dimensional double immunodiffusion (ID), complement fixation (CF), immunofluorescence (IF), reversed passive hemagglutination (RPHA) of antibody-coated red cells, immune electron microscopy (IEM), immunoelectroosmophoresis (IEOP), and radioimmunoassay (RIA). Academic Press Inc. Published by Elsevier Inc. 1970 2008-02-28 /pmc/articles/PMC7131679/ /pubmed/4993220 http://dx.doi.org/10.1016/S0065-3527(08)60027-5 Text en © 1970 Academic Press Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bouvier, George L. Le McCollum, Robert W. Australia (Hepatitis-Associated) Antigen: Physicochemical And Immunological Characteristics |
title | Australia (Hepatitis-Associated) Antigen: Physicochemical And Immunological Characteristics |
title_full | Australia (Hepatitis-Associated) Antigen: Physicochemical And Immunological Characteristics |
title_fullStr | Australia (Hepatitis-Associated) Antigen: Physicochemical And Immunological Characteristics |
title_full_unstemmed | Australia (Hepatitis-Associated) Antigen: Physicochemical And Immunological Characteristics |
title_short | Australia (Hepatitis-Associated) Antigen: Physicochemical And Immunological Characteristics |
title_sort | australia (hepatitis-associated) antigen: physicochemical and immunological characteristics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131679/ https://www.ncbi.nlm.nih.gov/pubmed/4993220 http://dx.doi.org/10.1016/S0065-3527(08)60027-5 |
work_keys_str_mv | AT bouviergeorgelle australiahepatitisassociatedantigenphysicochemicalandimmunologicalcharacteristics AT mccollumrobertw australiahepatitisassociatedantigenphysicochemicalandimmunologicalcharacteristics |